Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Glatiramer and steroid combination treatment beneficial in relapsing-remitting multiple sclerosis

Feb. 28, 2008

Mechanisms behind protective effects of KAI-9803 in stroke model determined

Feb. 28, 2008

PBT-2 shows safety and tolerability in patients with early Alzheimer's disease

Feb. 27, 2008

FDA accepts for review Forest and Cypress' NDA for milnacipran for fibromyalgia

Feb. 27, 2008

Positive preclinical results of S-0139 in ischemic stroke

Feb. 27, 2008

Recent patents report new psychopharmacologic agents

Feb. 26, 2008

Phase III AZ-004 trial begins in patients with schizophrenia or bipolar disorder

Feb. 26, 2008

Rosiglitazone neuroprotective mechanism in experimental stroke elucidated

Feb. 26, 2008

Reduced spinal cord opioid receptor mRNA and antinociception in MS mouse model

Feb. 26, 2008

MK-0343 has different effects on healthy volunteers than lorazepam

Feb. 26, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...